These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16728460)

  • 1. Development of comprehensive disease assessment in systemic vasculitis.
    Flossmann O; Bacon P; de Groot K; Jayne D; Rasmussen N; Seo P; Westman K; Luqmani R
    Ann Rheum Dis; 2007 Mar; 66(3):283-92. PubMed ID: 16728460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of comprehensive disease assessment in systemic vasculitis.
    Flossmann O; Bacon P; de Groot K; Jayne D; Rasmussen N; Seo P; Westman K; Luqmani R
    Postgrad Med J; 2008 Mar; 84(989):143-52. PubMed ID: 18372486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biological assessment in systemic necrotizing vasculitides.
    Mukhtyar CB; Flossmann O; Luqmani RA
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S92-9. PubMed ID: 16859602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases.
    Ponte C; Sznajd J; O'Neill L; Luqmani RA
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-118-25. PubMed ID: 25365100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of systemic vasculitis.
    Miller A; Basu N; Luqmani R
    Autoimmun Rev; 2008 Dec; 8(2):170-5. PubMed ID: 18672099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity, damage and outcome in systemic vasculitis.
    Carruthers D; Bacon P
    Best Pract Res Clin Rheumatol; 2001 Jun; 15(2):225-38. PubMed ID: 11469819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing disease activity in the systemic vasculitides.
    Luqmani RA
    Curr Opin Rheumatol; 2002 Jan; 14(1):23-8. PubMed ID: 11790992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and assessment of systemic vasculitis.
    McLaren JS; McRorie ER; Luqmani RA
    Clin Exp Rheumatol; 2002; 20(6):854-62. PubMed ID: 12508782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient assessment of systemic vasculitis.
    Nataraja A; Mukhtyar C; Hellmich B; Langford C; Luqmani R
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):713-32. PubMed ID: 17678832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of damage assessment in vasculitis.
    Seo P; Luqmani RA; Flossmann O; Hellmich B; Herlyn K; Hoffman GS; Jayne D; Kallenberg CG; Langford CA; Mahr A; Matteson EL; Mukhtyar CB; Neogi T; Rutgers A; Specks U; Stone JH; Ytterberg SR; Merkel PA
    J Rheumatol; 2007 Jun; 34(6):1357-71. PubMed ID: 17552062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
    Merkel PA; Seo P; Aries P; Neogi T; Villa-Forte A; Boers M; Cuthbertson D; Felson DT; Hellmich B; Hoffman GS; Jayne DR; Kallenberg CG; Krischer J; Mahr A; Matteson EL; Specks U; Luqmani R; Stone J; ;
    J Rheumatol; 2005 Dec; 32(12):2488-95. PubMed ID: 16331794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI).
    Exley AR; Bacon PA; Luqmani RA; Kitas GD; Carruthers DM; Moots R
    Br J Rheumatol; 1998 Jan; 37(1):57-63. PubMed ID: 9487252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease assessment and management of the vasculitides.
    Luqmani RA; Exley AR; Kitas GD; Bacon PA
    Baillieres Clin Rheumatol; 1997 May; 11(2):423-46. PubMed ID: 9220084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides.
    Demirkaya E; Ozen S; Pistorio A; Galasso R; Ravelli A; Hasija R; Baskin E; Dressler F; Fischbach M; Garcìa Consuegra J; Iagaru N; Pasic S; Scarpato S; van Rossum MA; Apaz MT; Barash J; Calcagno G; Gonzalez B; Hoppenreijs E; Ioseliani M; Mazur-Zielinska H; Vougiouka O; Wulffraat N; Luqmani R; Martini A; Ruperto N; Dolezalova P;
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S162-8. PubMed ID: 22640658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term prognosis and outcome of patients with primary systemic vasculitis: initial results in Germany].
    Herlyn K; Gross WL; Reinhold-Keller E
    Z Rheumatol; 2000 Apr; 59(2):131-4. PubMed ID: 10868023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
    Dolezalova P; Price-Kuehne FE; Özen S; Benseler SM; Cabral DA; Anton J; Brunner J; Cimaz R; O'Neil KM; Wallace CA; Wilkinson N; Eleftheriou D; Demirkaya E; Böhm M; Krol P; Luqmani RA; Brogan PA
    Ann Rheum Dis; 2013 Oct; 72(10):1628-33. PubMed ID: 23100606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome measures in ANCA-associated vasculitis.
    Suppiah R; Robson J; Luqmani R
    Rheum Dis Clin North Am; 2010 Aug; 36(3):587-607. PubMed ID: 20688252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VASCULITIDES IN CHILDHOOD].
    Jelušić M; Frković M
    Reumatizam; 2016; 63 Suppl 1():80-5. PubMed ID: 29624307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.
    Exley AR; Bacon PA; Luqmani RA; Kitas GD; Gordon C; Savage CO; Adu D
    Arthritis Rheum; 1997 Feb; 40(2):371-80. PubMed ID: 9041949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining disease activity and damage in patients with small-vessel vasculitis.
    Merkel PA
    Cleve Clin J Med; 2012 Nov; 79 Suppl 3():S11-5. PubMed ID: 23203638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.